site map

News Releases

2008
2007
2006
2005
2004

 

    
  June 17, 2008 Protox Granted Orphan Status In Europe For Brain Cancer Treatment
  May 23, 2008 Protox Completes $4.8 Million Private Placement
  May 20, 2008 Protox to Present BPH Data at AUA Conference
  May 15, 2008 Protox Doses First Patient In Phase 2 BPH Clinical Trial
  May 13, 2008 Protox Reports 2008 First Quarter Results
  May 5, 2008 Protox Announces Private Placement
  April 30, 2008 Protox Announces Collaboration with FDA
  April 16, 2008 Protox Announces Positive Long-Term Data From BPH Study
  April 15, 2008 Protox Reports 2007 Financial Results And Achievements
  April 8, 2008 Protox Initiates Phase 2 BPH Study
  February 13, 2008 Protox To Present Prostate Cancer Data At ASCO Conference
  January 30, 2008 Protox To Graduate To Toronto Stock Exchange
  January 15, 2008 Protox Initiates Phase 2 Prostate Cancer Study
  January 7, 2008 Protox Appoints Vice President, Business Development & Strategy
  January 3, 2008 Protox Announces Positive Final Results From BPH Study

2006 Protox Therapeutics Inc. All Rights Reserved. Legal Disclaimer.

What's New

June 17, 2008
Protox Granted Orphan Status In Europe For Brain Cancer Treatment

May 23, 2008
Protox Completes $4.8 Million Private Placement

May 20, 2008
Protox to Present BPH Data at AUA Conference

May 15, 2008
Protox Doses First Patient In Phase 2 BPH Clinical Trial

 

Events

BioFinance
Toronto Marriott Eaton Centre Hotel (Trinity IV room) - Toronto, ON

When: May 7, 2008 10:30a.m. EDT

Presenter: Dr. Fahar Merchant, President & CEO

 

Stock Quote

LAST TRADE:$0.64
TRADE TIME:11:17AM EST
CHANGE:$-0.04 (-5.88%)
PREV CLOSE: $0.68
OPEN:$0.64
BID:$0.64
ASK:$0.72